Literature DB >> 14726399

Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis.

Shinsuke Yasuda1, Tatsuya Atsumi, Masahiro Ieko, Eiji Matsuura, Kazuko Kobayashi, Junko Inagaki, Hisao Kato, Hideyuki Tanaka, Minoru Yamakado, Minoru Akino, Hisatoshi Saitou, Yoshiharu Amasaki, Satoshi Jodo, Olga Amengual, Takao Koike.   

Abstract

BEta(2)-glycoprotein I (beta(2)-GPI) is proteolytically cleaved by plasmin in domain V (nicked beta(2)-GPI), being unable to bind to phospholipids. This cleavage may occur in vivo and elevated plasma levels of nicked beta(2)-GPI were detected in patients with massive plasmin generation and fibrinolysis turnover. In this study, we report higher prevalence of elevated ratio of nicked beta(2)-GPI against total beta(2)-GPI in patients with ischemic stroke (63%) and healthy subjects with lacunar infarct (27%) when compared to healthy subjects with normal findings on magnetic resonance imaging (8%), suggesting that nicked beta(2)-GPI might have a physiologic role beyond that of its parent molecule in patients with thrombosis. Several inhibitors of extrinsic fibrinolysis are known, but a negative feedback regulator has not been yet documented. We demonstrate that nicked beta(2)-GPI binds to Glu-plasminogen with K(D) of 0.37 x 10(-6) M, presumably mediated by the interaction between the fifth domain of nicked beta(2)-GPI and the fifth kringle domain of Glu-plasminogen. Nicked beta(2)-GPI also suppressed plasmin generation up to 70% in the presence of tissue plasminogen activator, plasminogen, and fibrin. Intact beta(2)-GPI lacks these properties. These data suggest that beta(2)-GPI/plasmin-nicked beta(2)-GPI controls extrinsic fibrinolysis via a negative feedback pathway loop.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14726399     DOI: 10.1182/blood-2003-08-2712

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

Review 1.  Impaired fibrinolysis in the antiphospholipid syndrome.

Authors:  Katie A Krone; Kristi L Allen; Keith R McCrae
Journal:  Curr Rheumatol Rep       Date:  2010-02       Impact factor: 4.592

Review 2.  Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Authors:  Leigh Anderson
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

3.  Dietary oil modifies the plasma proteome during aging in the rat.

Authors:  Mónica Santos-González; José López-Miranda; Francisco Pérez-Jiménez; Plácido Navas; José M Villalba
Journal:  Age (Dordr)       Date:  2011-04-07

4.  Plasmin-cleaved beta-2-glycoprotein 1 is an inhibitor of angiogenesis.

Authors:  Taro Sakai; Krishnakumar Balasubramanian; Sourindra Maiti; Jyotsna B Halder; Alan J Schroit
Journal:  Am J Pathol       Date:  2007-09-14       Impact factor: 4.307

5.  beta2-glycoprotein i is a cofactor for tissue plasminogen activator-mediated plasminogen activation.

Authors:  Chunya Bu; Lei Gao; Weidong Xie; Jainwei Zhang; Yuhong He; Guoping Cai; Keith R McCrae
Journal:  Arthritis Rheum       Date:  2009-02

Review 6.  Annexin A2: biology and relevance to the antiphospholipid syndrome.

Authors:  E Cockrell; R G Espinola; K R McCrae
Journal:  Lupus       Date:  2008-10       Impact factor: 2.911

7.  IgG antibodies to plasminogen and their relationship to IgG anti-beta(2)-glycoprotein 1 antibodies and thrombosis.

Authors:  Chunya Bu; Zhihuan Li; Chune Zhang; Lei Gao; Guoping Cai
Journal:  Clin Rheumatol       Date:  2007-07-24       Impact factor: 2.980

Review 8.  The Pathophysiology of The Antiphospholipid Syndrome: A Perspective From The Blood Coagulation System.

Authors:  R Arreola-Diaz; A Majluf-Cruz; L E Sanchez-Torres; J Hernandez-Juarez
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 2.389

Review 9.  Antiphospholipid antibodies: paradigm in transition.

Authors:  Lawrence L Horstman; Wenche Jy; Carlos J Bidot; Yeon S Ahn; Roger E Kelley; Robert Zivadinov; Amir H Maghzi; Masoud Etemadifar; Seyed Ali Mousavi; Alireza Minagar
Journal:  J Neuroinflammation       Date:  2009-01-20       Impact factor: 8.322

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.